Palvella Therapeutics Chief Scientific Officer Jeff Martini, Ph.D. Selected to Present at Upcoming FDA Public Workshop on Drug Repurposing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. ROIV
5. ORCL
6. QCOM
7. IONS
8. AAPL
9. HOOD
10. TTAN

Go back to Palvella Therapeutics Chief Scientific Officer Jeff Martini, Ph.D. Selected to Present at Upcoming FDA Public Workshop on Drug Repurposing
(NASDAQ: PVLA) Delayed: 152.28 --0 (-0%)
Previous Close $152.28    52 Week High $ 
Open $152.28    52 Week Low $ 
Day High $152.28    P/E N/A 
Day Low $152.28    EPS $ 
Volume 801